← Leaderboards
Paul Andrew Davies
Tufts University Boston
$3,367,637
Attributed
$5,627,486
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $813.7K · FY2009–23$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$5,627,486 · 6
By mechanism
R01$4,069,848 · 2
R21$1,557,638 · 4
Top collaborators
- Stephen J Moss15 shared
Most similar at Tufts University Boston
Same institution · by research overlap
- Tarek Ziad Deeb$1,404,096
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingNeuronsBrainTraffickingMembranePhosphorylationEpilepsyReceptorNeurosteroidsNeuronal ExcitabilityGamma-Aminobutyric AcidSerineCell MembraneGaba-A ReceptorModificationNeuronal CircuitryPlaySignal TransductionLeadPremenstrual SyndromeComparative EfficacyNovel Therapeutic InterventionBehaviorAnxiety
Grant awards (20)
Rescuing KCC2 Dysfunction in CDKL5 Deficiency Disorder to Restore GABA(A) Receptor-Mediated Hyperpolarization and Seizure Protection.$204,300
R21 · FY2023 · NS · contact PI
Novel actions of neurosteroids on GABA (A) receptor trafficking$361,898
R01 · FY2022 · NS · contact PI
Rescuing KCC2 dysfunction in CDKL5 Deficiency Disorder to restore GABA(A) receptor-mediated hyperpolarization and seizure protection.$245,550
R21 · FY2022 · NS · contact PI
Novel actions of neurosteroids on GABA (A) receptor trafficking$67,288
R01 · FY2022 · NS · contact PI
Novel actions of neurosteroids on GABA (A) receptor trafficking$361,898
R01 · FY2021 · NS · contact PI
Sensory Hypersensitivity in Fragile X Syndrome Due to Deficits in Tonic Inhibition Reversed by Neuroactive Steroids$204,300
R21 · FY2021 · NS · contact PI
Novel actions of neurosteroids on GABA (A) receptor trafficking$80,745
R01 · FY2021 · NS · contact PI
Novel actions of neurosteroids on GABA (A) receptor trafficking$53,830
R01 · FY2021 · NS · contact PI
Novel actions of neurosteroids on GABA (A) receptor trafficking$361,898
R01 · FY2020 · NS · contact PI
Sensory Hypersensitivity in Fragile X Syndrome Due to Deficits in Tonic Inhibition Reversed by Neuroactive Steroids$245,550
R21 · FY2020 · NS · contact PI
Determining the effects of human KCC2 mutations on neuronal excitability$206,250
R21 · FY2020 · NS · contact PI
Novel actions of neurosteroids on GABA (A) receptor trafficking$361,898
R01 · FY2019 · NS · contact PI
Novel actions of neurosteroids on GABA (A) receptor trafficking$361,898
R01 · FY2018 · NS · contact PI
Novel actions of neurosteroids on GABA (A) receptor trafficking$404,699
R01 · FY2017 · MH · contact PI
Novel actions of neurosteroids on GABA (A) receptor trafficking$404,699
R01 · FY2016 · MH · contact PI
Novel actions of neurosteroids on GABA (A) receptor trafficking$404,699
R01 · FY2015 · MH · contact PI
Novel actions of neurosteroids on GABA (A) receptor trafficking$404,699
R01 · FY2014 · MH · contact PI
Novel actions of neurosteroids on GABA (A) receptor trafficking$439,699
R01 · FY2013 · MH · contact PI
Ethanol Modulation of Zinc-Activated Channels$204,188
R21 · FY2010 · AA · contact PI
Ethanol Modulation of Zinc-Activated Channels$247,500
R21 · FY2009 · AA · contact PI